Articles tagged with: GSK
Gilead Sciences, Inc. (NASDAQ:GILD) in partnership with the GlaxoSmithKline plc (ADR) (NYSE:GSK) today has announced their plans for an international clinical trial to study the combination therapy versus monotherapy in a first-line treatment setting for pulmonary …
Theravance, Inc. (NASDAQ:THRX) today announced that they have commence Phase 3 of Horizon programme with GlaxoSmithKline plc (ADR) (NYSE:GSK) to develop a next generation treatment for COPD.
On Monday morning, the Food and Drug Administration panel approved Arzerra, a leukemia treatment that will be marketed and commercialized by GlaxoSmithKline Plc (ADR) (NYSE:GSK).
It was a nice Monday morning for GSK when they made an announcement that the Food and Drug Administration has voted in the favor of their new cancer drug Votrient.
On early Monday morning GlaxoSmithKline has decided to pay upfront fees and milestone payments to the Dutch biotech company Prosensa. GSK has committed to pay the upfront fees of US$ 680 million to Prosensa for …
GSK, one of the top pharmaceutical companies, is facing new delays over the approval of their vaccine Cervarix that is aimed for the treatment of cervical cancers. GSK said that the reason for delay is …
Swine Flu, officially known as N1H1 influenza , is having a far reaching effect on every one of us. The virus was first tracked in a small town in Mexico in May of 2009 and …
In April 2009 the nation received scary news; a virus was sweeping through Mexico and South America, and had reached the Southwestern United States. That virus was Swine Flu or H1N1, an influenza virus affectionately …
